World Orphan Drug Congress USA 2024

23 - 25.04.2024
SKC is excited to announce that we will be attending the World Orphan Drug Congress USA 2024, the most important and comprehensive event for the rare disease industry. The event will take place on April 23-25, 2024 at the Boston Convention and Exhibition Center, Boston, MA.
Boston, USA, 23 - 25.04.2024

The World Orphan Drug Congress USA brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies for rare disease patients.

"Cell and gene therapy access and reimbursement challenges in Europe" is the title of a panel discussion, moderated by Dr Alexander Natz, Director General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs. SKC's founder and managing director, Prof. Matthias P. Schönermark M.D., Ph.D. will discuss this important topic together with other industry experts ( 24 April at 4:00 pm). 

We look forward to connecting with you at the World Orphan Drug Congress USA 2024 and sharing our insights and expertise on rare diseases.

Get in touch

Ihr Ansprechpartner Prof. Matthias P. Schönermark, M.D., Ph.D.
Prof. Matthias P. Schönermark, M.D., Ph.D.
Founder and Managing Director
Fon: +49 511 64 68 14 – 0
Fax: +49 511 64 68 14 18

Orphan drugs in Germany

Orphan drugs and the specific market access challenges are at the core of our expertise.

Full Market Access

Hands-on support throughout the whole process: from strategic positioning all the way to price negotiation, we accompany you seamlessly.
to the top